NIH Budget Plan Means Cutbacks For Biomedical Research

Bush asks for expansion in grants and minority training, but his 4.7% projected increase falls short of rising lab costs. WASHINGTON--Despite a budget that Health and Human Services Secretary Louis Sullivan says maintains an "unprecedented level of support" for biomedical research, the president's request for 1991 falls short of what's needed to sustain a flourishing biomedical enterprise. President Bush is asking for $7.9 billion next year for the National Institutes of Health, a 4.7% increa

Written byElizabeth Pennisi
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Bush asks for expansion in grants and minority training, but his 4.7% projected increase falls short of rising lab costs.
WASHINGTON--Despite a budget that Health and Human Services Secretary Louis Sullivan says maintains an "unprecedented level of support" for biomedical research, the president's request for 1991 falls short of what's needed to sustain a flourishing biomedical enterprise.

President Bush is asking for $7.9 billion next year for the National Institutes of Health, a 4.7% increase over present spending. That request includes such welcome increases as: an increase from 4,633 to 5,095 in the number of new and competing extramural research grants; 225 more postdoctoral trainees, bringing the total to a new high of 12,020; a $48 million increase, to $108 million, in the Human Genome Initiative; and $57 million more to fight AIDS, bringing the Public Health Service total to $1.7 billion.

Other increases are meant to encourage more minorities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies